Oncologist Patrizia Paterlini: «I look for tumor cells before the tumor becomes visible, which is why I patented a test that looks for tumor cells in the blood in the very early stages of development» “I chose research because, as an oncologist, I saw too many patients die—I felt powerless,” says the researcher who […]
Vanity Fair Italy Interviews Rarecells Founder Dr. Patrizia Paterlini Read More »
NEW YORK, NY and PARIS, FRANCE – June 18, 2025 Rarecells, Inc., a leader in liquid biopsy technology, is pleased to announce the appointment of Dr. Rita Shaknovich to its Scientific Advisory Board. Dr. Shaknovich brings over 20 years of leadership experience across private industry and academia. She has a distinguished track record of building
Rarecells, Inc. Appoints Dr. Rita Shaknovich to Scientific Advisory Board Read More »
NEW YORK – (March 26, 2025) – Rarecells, Inc., a pioneering company in liquid biopsy, is pleased to announce the appointment of Dr. Neil Kurtz to its Board of Directors. Dr. Kurtz, a renowned healthcare entrepreneur and executive, brings over 40 years of experience in the pharmaceutical, contract research, post-acute care, and medical diagnostic sectors.
Press Release: Rarecells, Inc. Appoints Dr. Neil Kurtz to Board of Directors Read More »
NEW YORK, Sept. 6, 2022 /PRNewswire/ — Rarecells, Inc. today announced the appointment of Dr. Neil Gunn, a recognized leader and expert in the diagnostic space, as an independent Board Director. “We are delighted to welcome Neil as Board Director. With his broad understanding of diagnostics and the Liquid Biopsy space he is well-positioned to provide valuable perspectives
Press Release: Rarecells announces Appointment of New Director to the Board Read More »
We are delighted to join the prestigious The Oncology Think Tank, initiated by Prof. Azra Raza – Director of the MDS Center at Columbia University in New York, USA. We aim to provide patients with blood tests that diagnose cancer well before the moment medical imaging analyses are able to detect the tumor mass, making cancer
Attend the Keynote presentation ”New non-invasive approaches for early diagnosis and follow up of invasive cancers” of Prof. Patrizia Paterlini-Bréchot, CSO of Rarecells Diagnostics, during the 2nd Liquid Biopsies Congress, which will be held virtually and free to attend upon registration. Save the date: Thursday 2020, 08th October at 4:20 pm. For more information and
2nd Liquid Biopsies Congress – Global Exchange Read More »
[OPPORTUNITY] – Rarecells is looking to hire a Research Lab Director! 🧬🦠🔬 For more info: www.rarecells.com/careers
Attend the Keynote presentation ” Clinical Applications of Circulating Tumor Cells in Predictive Oncology ” of Prof. Patrizia Paterlini-Bréchot, CSO of Rarecells Diagnostics, during the Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2019 Conference in Rotterdam. Save the date: Wednesday 2019, 30th October at 09:45 am. For more information visit: https://www.selectbiosciences.com/conferences/biographies.aspx?speaker=1472017&conf=EXLBPEU2019
Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2019 Conference Read More »
https://actc2019.org Rarecells Diagnostics will be present at the 4th Advances in Circulating Tumor Cells congress, from 2 to 5 October 2019 in Corfu, Greece. We welcome you at our booth #4!
4th ACTC Congress VISIT US! Read More »
Innovation Forum Follow Prof. Patrizia Paterlini Brechot, Founder & CSO of Rarecells Diagnostics, in the panel discussion “Prevention, early detection and future therapies in oncology” at Health Horizons Future Healthcare Forum in #Cambridge Innovation Forum Find out more here: https://www.horizons.health/
Health Horizons Future Healthcare Forum Read More »
Paris, France
Please enter the requested information below and click SEND
Please enter the requested information below and click SEND
Please enter the requested information below and click SEND